2026.06.18 G.S.R. 496(E)_Notification of Chaudhary Charan Singh National Institute of Animal Health, Baghpat, UP, as a CDL for testing viral and bacterial veterinary vaccines under the D and C Act

Posted by: Prabhas Chakraborty June 24, 2026

What's New 2?

Regulation/Guidelines

Stem Cell Regulation in India: Separating Legitimate Therapy Development from Regulatory Risk

Introduction Stem cell therapy represents one of the most scientifically promising and regulatorily complex frontiers in modern medicine. India's stem cell regulatory landscape presents both genuine opportunity and significant compliance...

10th July, 2026

Regulation/Guidelines

Cosmetic Labelling in India: CDSCO, , and Legal Metrology — Three Bodies, One Label

Three Regulatory Bodies, One Physical Label A Cosmetic label entering India is reviewed — directly or through market surveillance — against the requirements of three separate regulatory frameworks: CDSCO's Cosmetics...

8th July, 2026

Regulation/Guidelines

New Medical Device in India: When MD-22, MD-23, MD-26, and MD-27 Apply

India's Medical Devices Rules, 2017 (MDR 2017) has a distinct regulatory pathway for Devices classified as New Medical Devices — a category that carries additional scrutiny, documentation requirements, and in...

7th July, 2026

Regulation/Guidelines

How Global Biotech Companies Should Adapt Their CTD Dossiers for India

The Common Technical Document (CTD) is the universal language of Pharmaceutical and Biological registration. Most global regulatory agencies, including the USFDA, EMA and PMDA accept the ICH CTD format with...